Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

A single session of aerobic or resistance exercise modifies the endothelial progenitor cell levels in healthy subjects, but not in individuals with type 1 diabetes

Authors: Beatriz D Schaan, Gustavo Waclawovsky, Daniel Umpierre, Franciele R Figueira, Eliandra S de Lima, Ana P Alegretti, Laiana Schneider, Ursula S Matte, Ticiana C Rodrigues

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Endothelial progenitor cells (EPCs) from the bone marrow can regenerate the endothelium. In type 1 diabetes (T1D), EPCs are reduced as compared to healthy subjects, possibly accelerating endothelial dysfunction. Exercise mobilizes EPCs from bone marrow in some populations, but in T1D this was not previously studied. …
Metadata
Title
A single session of aerobic or resistance exercise modifies the endothelial progenitor cell levels in healthy subjects, but not in individuals with type 1 diabetes
Authors
Beatriz D Schaan
Gustavo Waclawovsky
Daniel Umpierre
Franciele R Figueira
Eliandra S de Lima
Ana P Alegretti
Laiana Schneider
Ursula S Matte
Ticiana C Rodrigues
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A251

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine